Dated disclosed rounds · latest 2022-01-01
Series B
Ori Biotech
Cell & gene therapy manufacturing hardware
VerifiedSeries BLondon
- Companies House
- 09757696
- GLEIF LEI
- 2138003DIOB5962WSM45
- Latest evidence
- 2022-01-01
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-01
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
7 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
IdentifierReference metadata LEI record updated
2138003DIOB5962WSM45 · registration ISSUED
FundingSource fact Series B
$100m+ · 3 named investors
IdentifierReference metadata LEI first registered
2138003DIOB5962WSM45
FundingSource fact Series A
$30M · 5 named investors
FundingSource fact Seed
$9.4M (£7M) · 5 named investors
RegistryRegistry fact Company incorporated
ORIBIOTECH LTD · company 09757696
Latest disclosed round
Series B
- Date
- 2022-01-01
- Amount
- USD 100m
- Sector
- Deeptech / hardware
- Companies House
- 09757696
- ONS region
- London
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
4 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
Novalis LifeSciencesleadChimera Abu DhabiparticipantKindred CapitalparticipantPuhua Capitalparticipant
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| Novalis LifeSciences | lead | 2022-01-01 | Oribiotech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Chimera Abu Dhabi | participant | 2022-01-01 | Oribiotech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Kindred Capital | participant | 2026-08-25 | Oribiotech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Puhua Capital | participant | 2022-01-01 | Oribiotech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
3 disclosed rounds
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2022-01-01 | Series B | $100m+ | Novalis LifeSciences · Puhua Capital · Chimera Abu Dhabi | Oribiotech ↗ |
| 2020-10-14 | Series A | $30M | Northpond Ventures · Octopus Ventures · Amadeus Capital Partners · Kindred Capital · 1 additional source-listed name | PR Newswire ↗ · Oribiotech ↗ |
| 2020-01-09 | Seed | $9.4M (£7M) | Amadeus Capital Partners · Kindred Capital · 3 additional source-listed names | PR Newswire ↗ |
Companies House status and filing snapshot
ORIBIOTECH LTD
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2015-09-02
- Dissolved
- Not applicable
- Company number
- 09757696
Filing context
- Accounts category
- GROUP
- Accounts made up to
- 2024-12-31
- Next accounts due
- 2026-09-30
- Confirmation made up to
- 2025-07-09
- Registry snapshot
- 2026-08-01
- Live check
- Bulk snapshot only
71121Engineering design activities for industrial process and production71200Technical testing and analysis72110Research and experimental development on biotechnology72190Other research and experimental development on natural sciences and engineering
Global legal-entity identifier
2138003DIOB5962WSM45
Exact company-number match to the GLEIF golden-copy data. An LEI is an identifier for a legal entity; it is not a credit, risk or investment-quality rating.
GLEIF record
- Legal name
- ORIBIOTECH LTD
- Entity status
- ACTIVE
- Jurisdiction
- GB
- Registration status
- ISSUED
- Last updated
- 2025-10-27T11:36:30.760Z
- Next renewal
- 2026-12-16T00:00:00Z
Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.